Needs-based considerations for the role of low-dose aspirin along the CV risk continuum
Cardiovascular disease (CVD) remains the leading cause of death worldwide. The risk of a cardiovascular (CV) event is not static and increases along a continuum, making identification and management complex.Aspirin has been the cornerstone of antiplatelet therapy in CV risk reduction and remains the...
Saved in:
Main Authors: | Francesca Santilli (Author), Gerhard Albrecht (Author), Michael Blaha (Author), Angel Lanas (Author), Li Li (Author), Dirk Sibbing (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advanced subclinical atherosclerosis: A novel category within the cardiovascular risk continuum with distinct treatment implications
by: Michael J. Blaha, et al.
Published: (2023) -
Implications of the heterogeneity between guideline recommendations for the use of low dose aspirin in primary prevention of cardiovascular disease
by: Xiao-Ying Li, et al.
Published: (2022) -
Phosphorus Along the Soil-Freshwater-Ocean Continuum
Published: (2019) -
Stroke survivors' experiences of team support along their recovery continuum
by: W. Hartford, et al.
Published: (2019) -
How Family Physicians Practice the Principle of Remission Along the Glycemic Continuum
by: Stephanie T. Fulleborn, et al.
Published: (2020)